SCHEMBL18629031

SCHEMBL18629031

NNC1CCCCC1Nc1nc(-c2c[nH]c3ncc(Cl)cc23)ncc1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10007970 0.92 CDC7 (0.46) —
SCHEMBL10303579 0.92 CDC7 (0.46) —
SCHEMBL10007974 0.92 CDC7 (0.46) —
SCHEMBL10304329 0.87 CDC7 (0.47) —
SCHEMBL18052000 0.83 CDC7 (0.48) —
SCHEMBL10007203 0.82 CDC7 (0.44) —
SCHEMBL10008040 0.82 — —
SCHEMBL10008036 0.82 — —
SCHEMBL18052153 0.82 — —
SCHEMBL18739757 0.81 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3141252-A1 INHIBITORS OF INFLUENZA VIRUSES REPLICATION Vertex Pharmaceuticals Inc. (US) 2017-03-15 — — EP disclosed
Send feedback